Korean J Obstet Gynecol.
2002 Jan;45(1):122-125.
Comparison of Systemic and Transvaginal Local Methotrexate Treatment in Unruptured Ectopic Pregnancy
- Affiliations
-
- 1Department of Obstetrics and Gynecology, College of Medicine, Dan Kook University, Cheonan, Korea.
Abstract
OBJECTIVE
This study was performed to evaluate the efficacy of treating of unruptured ectopic pregnancy by systemic and transvaginal local administration of methotrexate.
METHODS
We reviewed the medical records of 32 patients who were treated with methotrexate from June 1995 to October 1999. Among the patients, 14 were treated by ultrasound-guided transvaginal local injection and 18 were treated by systemic intramuscular administration. Success rate of the treatment was examined for each group, and the cases of methotrexate failure were characterized and compared with the success group.
RESULTS
The success rate was similar between the transvaginal (85.7%) and the systemic (77.8%) groups. There were no differences in initial serum hCG levels, size of gestational sac, fetal cardiac activity between the success group and failure group.
CONCLUSION
The results of this study suggest that there is no difference in efficacy between systemic and transvaginal local methotrexate administration, and there are no useful parameters in identifying the risk for the failure of methotrexate treatment.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Cervical Pregnancy Treated by both Intraamniotic and Systemic Methotrexate Injection
- The clinical efficacy of single - dose methotrexate in unruptured tubal pregnancy
- Successful treatment with methotrexate injection on ectopic pregnancy embedded in the myometrium of a previous cesarean section scar
- A Case of Cervical Pregnancy Treated by Intra-ovular Injection of Methotrexate
- A case of ectopic pregnancy in the previous cesarean section scar treated by transvaginal hysterotomy
